Coca-Cola Consolidated, Inc. To Release First Quarter 2020 Results
CHARLOTTE, N.C., April 21, 2020 (GLOBE NEWSWIRE) — Coca-Cola Consolidated, Inc. (NASDAQ: COKE) will issue a news release after the […]
Triumph Bancorp Changes Its 2020 Annual Meeting of Stockholders to a Virtual Format
DALLAS, April 21, 2020 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (NASDAQ: TBK) (the “Company”) announced today that, due to the […]
Meridian Bancorp, Inc. Reports First Quarter Net Income with a Rise in Pre-Tax Core Earnings and Net Interest Margin Expansion to 3%
BOSTON, April 21, 2020 (GLOBE NEWSWIRE) — Meridian Bancorp, Inc. (the “Company” or “Meridian”) (NASDAQ: EBSB), the holding company for […]
Beyond Meat® to Report First Quarter 2020 Financial Results on May 5, 2020
EL SEGUNDO, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, announced […]
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update
JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in […]
Shockwave Medical to Report First Quarter 2020 Financial Results on May 12, 2020
SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and […]
Manhattan Associates Reports Record First Quarter 2020 Revenue
ATLANTA , April 21, 2020 (GLOBE NEWSWIRE) — Leading Supply Chain and Omnichannel Commerce Solutions provider Manhattan Associates Inc. (NASDAQ: […]
Appian Schedules First Quarter 2020 Financial Results Conference Call
MCLEAN, Va., April 21, 2020 (GLOBE NEWSWIRE) — Appian (NASDAQ: APPN) today announced that it will release financial results for […]
Abeona Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and CLEVELAND, April 21, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene […]
FDA Grants Passage Bio Orphan Drug Designation for PBGM01 for Treatment of Infantile GM1 Gangliosidosis
PHILADELPHIA, April 21, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative […]
